Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma

Abstract The purpose of this study was to investigate the association of Epstein-Barr virus (EBV) with peripheral blood immune cell counts and clinical outcomes in advanced nasopharyngeal carcinoma (NPC) patients. In a retrospective design, 146 patients with NPC at stage IV were enrolled in this stu...

Full description

Bibliographic Details
Main Authors: Dan Tao, Ningning Zhang, Qingqing Huang, Chuang Ge, Qicheng Li, Shujie Li, Kegui Weng, Qishuai Guo, Jiangdong Sui, Can Wang, Xin Zhang, Ying Wang
Format: Article
Language:English
Published: Nature Portfolio 2020-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-78892-0
_version_ 1818570907798470656
author Dan Tao
Ningning Zhang
Qingqing Huang
Chuang Ge
Qicheng Li
Shujie Li
Kegui Weng
Qishuai Guo
Jiangdong Sui
Can Wang
Xin Zhang
Ying Wang
author_facet Dan Tao
Ningning Zhang
Qingqing Huang
Chuang Ge
Qicheng Li
Shujie Li
Kegui Weng
Qishuai Guo
Jiangdong Sui
Can Wang
Xin Zhang
Ying Wang
author_sort Dan Tao
collection DOAJ
description Abstract The purpose of this study was to investigate the association of Epstein-Barr virus (EBV) with peripheral blood immune cell counts and clinical outcomes in advanced nasopharyngeal carcinoma (NPC) patients. In a retrospective design, 146 patients with NPC at stage IV were enrolled in this study. The association of EBV status with peripheral blood immune cell counts, distant metastases, and long-term survival in patients with advanced NPC were determined. Eighty-seven (59.6%) of all patients were positive for EBV. Compared with patients with normal NK cell count, patients with lower NK cell count showed a significantly lower EBV viral load (median: 614.0 vs. 2190.0 copies/mL, P = 0.024). EBV-positive patients showed a significantly higher incidence of liver metastasis than EBV-negative patients (32.6% vs. 23.7%, P = 0.021). Multi-variant regression analysis showed that EBV infection was independently associated with liver metastasis (OR: 2.33, P = 0.043). EBV positive patients showed a significantly worse PFS (P = 0.001) and OS (P = 0.001) than EBV negative patients. Multivariate Cox regression analysis revealed that EBV infection was independently associated with a worse PFS (HR: 1.94, P = 0.003), and OS (HR: 2.12, P = 0.014) in advanced NPC. In conclusion, EBV infection is associated with a high risk of liver metastasis and is also an independent negative predictor for PFS and OS in patients with advanced NPC. EBV infection is associated with lower CD8% and higher NK%, while lower NK cell count is associated with lower EBV viral load.
first_indexed 2024-12-14T13:48:20Z
format Article
id doaj.art-95716ff752ca4ce8a48065a3d8139afa
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T13:48:20Z
publishDate 2020-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-95716ff752ca4ce8a48065a3d8139afa2022-12-21T22:59:15ZengNature PortfolioScientific Reports2045-23222020-12-0110111110.1038/s41598-020-78892-0Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinomaDan Tao0Ningning Zhang1Qingqing Huang2Chuang Ge3Qicheng Li4Shujie Li5Kegui Weng6Qishuai Guo7Jiangdong Sui8Can Wang9Xin Zhang10Ying Wang11Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalChongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer HospitalDepartment of Nutrition, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Clinical Laboratory, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalAbstract The purpose of this study was to investigate the association of Epstein-Barr virus (EBV) with peripheral blood immune cell counts and clinical outcomes in advanced nasopharyngeal carcinoma (NPC) patients. In a retrospective design, 146 patients with NPC at stage IV were enrolled in this study. The association of EBV status with peripheral blood immune cell counts, distant metastases, and long-term survival in patients with advanced NPC were determined. Eighty-seven (59.6%) of all patients were positive for EBV. Compared with patients with normal NK cell count, patients with lower NK cell count showed a significantly lower EBV viral load (median: 614.0 vs. 2190.0 copies/mL, P = 0.024). EBV-positive patients showed a significantly higher incidence of liver metastasis than EBV-negative patients (32.6% vs. 23.7%, P = 0.021). Multi-variant regression analysis showed that EBV infection was independently associated with liver metastasis (OR: 2.33, P = 0.043). EBV positive patients showed a significantly worse PFS (P = 0.001) and OS (P = 0.001) than EBV negative patients. Multivariate Cox regression analysis revealed that EBV infection was independently associated with a worse PFS (HR: 1.94, P = 0.003), and OS (HR: 2.12, P = 0.014) in advanced NPC. In conclusion, EBV infection is associated with a high risk of liver metastasis and is also an independent negative predictor for PFS and OS in patients with advanced NPC. EBV infection is associated with lower CD8% and higher NK%, while lower NK cell count is associated with lower EBV viral load.https://doi.org/10.1038/s41598-020-78892-0
spellingShingle Dan Tao
Ningning Zhang
Qingqing Huang
Chuang Ge
Qicheng Li
Shujie Li
Kegui Weng
Qishuai Guo
Jiangdong Sui
Can Wang
Xin Zhang
Ying Wang
Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
Scientific Reports
title Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
title_full Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
title_fullStr Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
title_full_unstemmed Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
title_short Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
title_sort association of epstein barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
url https://doi.org/10.1038/s41598-020-78892-0
work_keys_str_mv AT dantao associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT ningningzhang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT qingqinghuang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT chuangge associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT qichengli associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT shujieli associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT keguiweng associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT qishuaiguo associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT jiangdongsui associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT canwang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT xinzhang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma
AT yingwang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma